Ambarella, Inc.Pembelian
Ambarella and Epizyme: breaking out or breaking bad?
The market-neutral spread of AMBA/EPZM broke out on Thursday (02/04/2015), in generally choppy trading conditions, showing clear signs of continuing its upward trend.
Up 4.67% for the day and closing near the high of its daily range, AMBA/EPZM shows good signs of posting sizeable gains over the coming months.
Ambarella is a semi-conductor stock that mainly serves the security and surveillance market and has seen a 162% increase in EPS since last quarter and a 62% increase sales over the same time period. It also has an annual ROE of just under 33% showing that management are making good use of their capital.
In comparison, Epizyme is a biomed/biotech stock that is bucking the strong sector performance trend by returning a decrease in EPS of -185% since last quarter and -72% in sales over the same time period. EPZM is definitely a laggard in a leading sector.
Anthony Walters 05/04/2015
Up 4.67% for the day and closing near the high of its daily range, AMBA/EPZM shows good signs of posting sizeable gains over the coming months.
Ambarella is a semi-conductor stock that mainly serves the security and surveillance market and has seen a 162% increase in EPS since last quarter and a 62% increase sales over the same time period. It also has an annual ROE of just under 33% showing that management are making good use of their capital.
In comparison, Epizyme is a biomed/biotech stock that is bucking the strong sector performance trend by returning a decrease in EPS of -185% since last quarter and -72% in sales over the same time period. EPZM is definitely a laggard in a leading sector.
Anthony Walters 05/04/2015
Pernyataan Penyangkalan
Informasi dan publikasi tidak dimaksudkan untuk menjadi, dan bukan merupakan saran keuangan, investasi, perdagangan, atau rekomendasi lainnya yang diberikan atau didukung oleh TradingView. Baca selengkapnya di Persyaratan Penggunaan.
Pernyataan Penyangkalan
Informasi dan publikasi tidak dimaksudkan untuk menjadi, dan bukan merupakan saran keuangan, investasi, perdagangan, atau rekomendasi lainnya yang diberikan atau didukung oleh TradingView. Baca selengkapnya di Persyaratan Penggunaan.